Biography

Prof. Dr. Kaiser Jamil, presently, Emeritus Scientist and Head of Genetics Department, Bhagwan Mahavir Medical Research Centre, Hyderabad, Telangana, India, has been former Principal Senior Scientist at CSIR’s Institutes like CCMB and IICT. She has contributed significantly in the area of Cancer Biology, Pharmacogenomics and Bioinformatics. Her research combines unusual versatility in adopting different areas like Molecular Biology, Bioinformatics and Pharmacogenomics for demonstrating the effect of some xenobiotics that cause various malignancies in at least 2% of the population. Her work on SNPs in apoptotic genes (XRCC1, XPD, BCL2, COX2) and drug metabolizing genes like CYPs and GSTs in various cancers (breast cancer, lung cancer and head and neck cancer) showed how DNA damage leads to disease progression, further her work on the polymorphisms of these genes determines the genotypes which could be categorized as poor, medium and fast metabolizers. This has made a significant impact in the scientific world as pharmacogenomics. Her group has succeeded in developing Models using bioinformatic tools for evaluating these polymorphisms for drug targeting as evidenced in her most recent publications on EGFR, MTHFR, P53, ATM, eNOS, PON1 and several other genes. Her work in the area of Acute Lymphocytic Leukemia (ALL, CML) was acclaimed as the best paper and their invention was filed as a patent along with her group where they use a statistical approach CHAID & DFA to have a holistic approach to evaluate the problem of childhood leukemia. She has published over 300 papers in peer reviewed journals and presented her work in international conferences. She is guiding PhD students in Cancer biology and bioinformatics projects using pharmacogenomics as the main area of research. She is on the editorial board of some prestigious journals and is a peer reviewer of several journals and continues her research in role of genes in diseases related to human health.

---

Research Interest

Molecular Biology, Bioinformatics and Pharmacogenomics